Enapril 2.5 mg Intas Pharmaceuticals
| Features | |
| Also known as | Enalapril maleate |
| Blood pressure | Reduces systolic and diastolic blood pressure |
| Chemical name | (2S)-1-[N-[(S)-1-Carboxy-3-phenylpropyl]-L-alanyl]-L-proline, dihydrate |
| Dosage (medical) | Typically starts at 5 mg once daily, adjusted as needed |
| Dosage (sports) | Not applicable |
| Effects | Reduction in blood pressure, improved heart function |
| Formula | C20H28N2O5В·2H2O |
| Half-life | Approximately 11 hours |
| Hepatotoxicity | Rare hepatotoxic effects |
| Lab Test | Monitoring of serum potassium and renal function recommended |
| Main action | Lowers blood pressure by inhibiting the conversion of angiotensin I to angiotensin II |
| Side effects | Cough, hypotension, dizziness, headache, fatigue |
| Storage conditions | Store at room temperature away from moisture and heat |
| Strength | 2.5 MG |
| Substance class | Angiotensin-converting enzyme (ACE) inhibitor |
| Trade name | Vasotec, Renitec, Enacard |
| Use in sports | Not typically used in sports |
| Water Retention | Low risk of water retention |
| Manufacturer | Intas Pharmaceuticals |